The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) - WKRN News 2

The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE ReportBuyer

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)

http://www.reportbuyer.com/pharma_healthcare/healthcare/market_hospital_acquired_infection_control_sterilization_disinfection_testing_treatment.html

Given the cost of hospital-acquired and healthcare-associated infections (HAIs), demand has increased for solutions that can help the healthcare industry reduce infections and the costs associated with them. The U.S. Centers for Disease Control and Prevention (CDC) estimates that around 1 in 20 or 5% of hospitalized patients will contract an HAI. Worldwide, the rate of nosocomial infections is between 3.5% and 12% of admissions in developed regions. This has created a market opportunity for companies that can test for, treat and help prevent these infections. This opportunity is detailed in Kalorama Information's report, The Market for Hospital-Acquired Infection Control (Sterilization, Cleaning, Testing, Treatment)

This report focuses on preventing, testing and treating infections in the healthcare environment. The major consideration is given to bacterial nosocomial infections because a) they are the most frequent type of infections spread in the health care delivery setting, and b) the practical aspects of diagnosis and therapy are more meaningful based on a combination of medical and financial considerations.

The report will provide a market analysis in the areas of Prevention, Testing and Treatment.

Market analysis in this report considers primarily the epidemiological considerations and the size patient groups both in the United States and globally, where available. We have accumulated the most recent data available, understanding that virtually no organization does extensive studies on these applications on a regular basis.

Many studies are highly localized and may only apply to a community, state or country (more often countries that are not a part of the major markets for nosocomial diagnostic and therapeutic products). In many instances, we have had to draw from broader epidemiologic data, that is, on data that reach outside of the hospital and primary care environment in order to construct a picture of the infection prevention, testing and treatment needs.

In looking at infections in the health environment, we consider the diagnostic and therapeutic technologies that are currently available and attempt to project trends for preventing, detecting and treating these infections. To some extent, we are limited by the activity of the industries associated with the activities mentioned above for these infections. For the most part, these activities are limited and the advanced technologies seen in other areas of medical application are not necessarily present in terms of microbiology.

The majority of competitive participation for Hospital-Acquired Infection control and is in the United States and Europe. However, competition is steadily escalating in the United States and Europe, which is encouraging more participation in other areas such as Asia and Latin America.

Companies in this report include:

• Advanced Sterilization Products
Becton Dickinson
• Belimed AG
• bioMerieux
• Cantel
• Cepheid
• Kimberly-Clark
• Merck & Co.
• Nordion
• Pfizer
• Roche
• Steris
• TSO3


CHAPTER ONE: EXECUTIVE SUMMARY
Overview

The Nosocomial Infection

Scope and Methodology
Total Size and Growth of the Market
Issues and Trends Affecting Market
Leading Competitors

CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS
Overview

Introduction to Pathogens
Classification of Antibacterial Organisms
Patient Risk Factors
General Infection Statistics
Populations at Risk for Infection

Demographics of the World

Life Expectancy
Nosocomial Infection Statistics
Common Hospital (nosocomial) Infections

Description of Infections

Infection Risk Assessments by Hospital Department

Burn Units
Intensive Care Units
Emergency Departments
Hospital Length of Stay
Extended Stay Environments

International Trends in Nursing Facilities

Economic Trends

Comparison Between Healthcare Spending and Real Health Outcomes


U.S. Government's National Plan to Prevent Healthcare Associated Infections (HAIs)

Steering Committee
The American Recovery and Reinvestment Act of 2009
Affordable Care Act (ACA) Funding
Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Funding

U.S. Statewide Standardized Infection Ratio
Reduction in Hospital Acquired Infections

Reduction in Infections in Israel
Burden of Hospital Acquired Infections
Hospital-Acquired Infection Surveillance Process

Case Studies

Arizona Prevention Study
Connecticut Funding for HAI Prevention and Reporting
Pennsylvania Study of HAI Admissions and Readmissions

Infections and Drug Resistance

Easing Approvals of Antibiotics
Causes of Drug Resistance

Antibiotic Abuse
Antibiotic Use in Agriculture

Drug Resistance in Select Populations

Children
The Elderly
Compromised Individuals

Measures for Reducing Resistance

Testing for the Selection of Anti-bacterial Therapy
Monitoring Therapy

Screening Hospitalized patients

Pharmaceutical Manufacturer and Marketer Trends

Trends in Partnerships and Alliances
Developers Trends

CHAPTER THREE: INFECTION PREVENTION
Overview

Methods of Transmission

Airborne
Contact
Droplet
Vehicle

High-Risk Facilities or Departments
Technology Overview

Potential Use of Copper for Reducing Infections
Wide Area Disinfection Methods
Software for Infection Detection and Control
Antiseptic-Coated Catheters

Sterilization vs. Disinfection

Sterilization
Disinfection

Equipment and Solutions
Heat/Steam Sterilization

Developments

Chemical Sterilization

Sterilants
Developments

Radiation Sterilization

Developments

Market Overview

Hospital-Acquired Infection Prevention Market by Geographical Region
Competitive Analysis

CHAPTER FOUR: INFECTION TESTING
Overview

Drug-Resistance/Susceptibility Testing
Genotypic Methods

DNA Sequencing
Solid-phase Hybridization Techniques
Microarrays
Real-time Polymerase Chain Reaction Techniques
Phenotypic Methods
Phage-based Assays
Colorimetric Methods
The Nitrate Reductase Assay

Specific Serious Hospital-Acquired Infection Testing

Acinetobacter Baumannii
Clostridium Difficile

Developments

Hospital-Acquired Pneumonia
Pseudomonas Aeruginosa
Staphylococcus Aureus

Methicillin-resistant Staphylococcus Aureus (MRSA)
Vancomycin-Intermediate/Resistant Staphylococcus Aureus (VISA/VRSA)
Developments

Tuberculosis

Developments

Urinary Tract Infections
Vancomycin-resistant Enterococcus

Developments

Ventilator-Associated Pneumonia

New Developments
Market Overview
Total Market Size and Forecast

Hospital-Acquired Infection Testing Market by Geographical Region

Competitive Analysis

CHAPTER FIVE: INFECTION TREATMENT
Overview
Principles of Anti-bacterial Therapy

Infecting Organism
Antibiotic Sensitivity Testing
Site of Infection
Host Defenses and Organ Function
Antibiotic Pharmacokinetics
Monitoring Therapy

Classifications of Antibacterial Products

Carbapenems
Cephalosporins
Macrolides
Penicillins
Quinolones
Sulfonamides
Tetracyclines

Treatment Guidelines

Clostridium Difficile
Gastroenteritis
Hospital-Acquired Pneumonia
Ventilator-associated Pneumonia
Pseudomonas Aeruginosa
Staphylococcus Aureus
Stenotrophomonas maltophilia
Tuberculosis
Urinary Tract Infections

Leading Products
New Developments
Total Market Size and Forecast
Hospital-Acquired Infection Treatment Market by Geographical Region
Competitive Analysis

CHAPTER SIX: MARKET OPPORTUNITIES FOR HOSPITAL-ACQUIRED INFECTION CONTROL
Market Considerations
Market Overview

Hospital-Acquired Infection Control Market by Geographical Region

CHAPTER SEVEN: COMPANY PROFILES
Introduction
Advanced Sterilization Products

Company Performance

Becton, Dickinson

Company Performance

Belimed

Company Performance

bioMerieux

Company Performance

Cantel

Company Performance

Cepheid

Company Performance

Getinge Group

Company Performance

Kimberly-Clark

Company Performance

Merck & Co

Company Performance

Nordion

Company Performance

Pfizer

Company Performance

Roche

Company Performance

Sakura Seiki
Steris

Company Performance

Tso3

Company Performance

LIST OF MAJOR PROVIDERS

Read the full report:
The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)

http://www.reportbuyer.com/pharma_healthcare/healthcare/market_hospital_acquired_infection_control_sterilization_disinfection_testing_treatment.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

441 Murfreesboro Road Nashville, TN 37210

Telephone: 615.369.7222
Fax: 615.369.7329
Email: news@wkrn.com

Can’t find something?
Powered by WorldNow
All content © Copyright 2000 - 2014 Young Broadcasting of Nashville, LLC. A Media General Company.